Axel Polack

4.9k total citations · 1 hit paper
54 papers, 3.0k citations indexed

About

Axel Polack is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Axel Polack has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 19 papers in Molecular Biology. Recurrent topics in Axel Polack's work include Viral-associated cancers and disorders (20 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immune Cell Function and Interaction (10 papers). Axel Polack is often cited by papers focused on Viral-associated cancers and disorders (20 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immune Cell Function and Interaction (10 papers). Axel Polack collaborates with scholars based in Germany, France and Switzerland. Axel Polack's co-authors include Riccardo Dalla‐Favera, Kou‐Juey Wu, Georg W. Bornkamm, Mario Amacker, Joachim Lingner, Carla Grandori, Dirk Eick, Alexander Pajic, Marino Schuhmacher and Martin S. Staege and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Axel Polack

53 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct activation of TERT transcription by c-MYC

1999 734 citations Axel Polack et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Polack Germany	27	1.5k	1.1k	612	602	592	54	3.0k
Jens Oliver Funk Germany	28	1.2k 0.8×	926 0.8×	450 0.7×	137 0.2×	270 0.5×	44	2.7k
Gemma L. Kelly Australia	30	2.3k 1.5×	1.9k 1.7×	700 1.1×	215 0.4×	837 1.4×	59	4.2k
Yair Gazitt United States	34	1.6k 1.1×	860 0.8×	678 1.1×	312 0.5×	156 0.3×	110	3.1k
Ruth W. Craig United States	29	2.3k 1.6×	965 0.9×	734 1.2×	116 0.2×	241 0.4×	44	3.3k
Ann Zeuner Italy	35	2.4k 1.6×	1.4k 1.2×	879 1.4×	581 1.0×	203 0.3×	72	4.3k
William E. Thierfelder United States	15	1.1k 0.7×	2.1k 1.9×	2.1k 3.5×	234 0.4×	234 0.4×	17	3.8k
Athanassios Kotsinas Greece	25	2.8k 1.9×	1.4k 1.3×	286 0.5×	411 0.7×	259 0.4×	70	3.9k
Katja Pokrovskaja Tamm Sweden	30	1.3k 0.9×	1.0k 0.9×	606 1.0×	103 0.2×	296 0.5×	62	2.4k
Cheryl Nickerson‐Nutter United States	28	774 0.5×	572 0.5×	1.8k 2.9×	249 0.4×	309 0.5×	44	3.2k
Didier Grillot United States	26	1.5k 1.0×	634 0.6×	976 1.6×	241 0.4×	102 0.2×	39	2.7k

Countries citing papers authored by Axel Polack

Since Specialization

Citations

This map shows the geographic impact of Axel Polack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Polack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Polack more than expected).

Fields of papers citing papers by Axel Polack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Polack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Polack. The network helps show where Axel Polack may publish in the future.

Co-authorship network of co-authors of Axel Polack

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Polack. A scholar is included among the top collaborators of Axel Polack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Polack. Axel Polack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Felix, Klaus, Axel Polack, Walter Pretsch, et al.. (2004). Moderate Hypermutability of a Transgenic lacZ Reporter Gene in Myc -Dependent Inflammation-Induced Plasma Cell Tumors in Mice. Cancer Research. 64(2). 530–537. 5 indexed citations

Fruci, Doriana, Grégoire Lauvau, Loredana Saveanu, et al.. (2003). Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport. The Journal of Immunology. 170(6). 2977–2984. 46 indexed citations

Hergenhahn, Manfred, Ubaldo Soto, Annette Weninger, et al.. (2002). The chemopreventive compound curcumin is an efficient inhibitor of Epstein‐Barr virus BZLF1 transcription in Raji DR‐LUC cells*. Molecular Carcinogenesis. 33(3). 137–145. 65 indexed citations

Pajic, Alexander, Martin S. Staege, Diana Dudziak, et al.. (2001). Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cells. International Journal of Cancer. 93(6). 810–816. 44 indexed citations

Pajic, Alexander, Dimitry Spitkovsky, B Christoph, et al.. (2000). Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. International Journal of Cancer. 87(6). 787–793. 164 indexed citations

Gerbitz, Armin, Josef Mautner, Christian Geltinger, et al.. (1999). Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene. 18(9). 1745–1753. 46 indexed citations

Teramoto, Norihiro, Katja Pokrovskaja Tamm, László Székely, et al.. (1999). Expression of cyclin D2 and D3 in lymphoid lesions. International Journal of Cancer. 81(4). 543–550. 37 indexed citations

Feuillard, Jean, Florence Poirier, Jean‐Pierre Le Caër, et al.. (1999). A computer-assisted two-dimensional gel electrophoresis approach for studying the variations in protein expression related to an induced functional repression of NFκB in lymphoblastoid cell lines. Electrophoresis. 20(4-5). 1017–1026. 20 indexed citations

Vogg, Gerd, et al.. (1999). Tumor promoters in commercial indoor-plant cultivars of the Euphorbiaceae.. Environmental Health Perspectives. 107(9). 753–756. 6 indexed citations

10.

Schuhmacher, Marino, Martin S. Staege, Alexander Pajic, et al.. (1999). Control of cell growth by c-Myc in the absence of cell division. Current Biology. 9(21). 1255–1258. 230 indexed citations

11.

Zimber‐Strobl, Ursula, Lothar J. Strobl, Bettina Kempkes, et al.. (1999). EBNA2 and c-myc in B Cell Immortalization by Epstein-Barr Virus and in the Pathogenesis of Burkitt’s Lymphoma. Current topics in microbiology and immunology. 246. 315–321. 8 indexed citations

12.

Herrmann, Thomas, et al.. (1998). Molecular cloning, structural organization, sequence, chromosomal assignment, and expression of the mouse alpha-N-acetylgalactosaminidase gene. Gene. 211(2). 205–214. 11 indexed citations

13.

Polack, Axel, Michael Pawlita, Heribert Bohlen, et al.. (1997). Suitability of Epstein–Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells. Gene Therapy. 4(2). 82–92. 32 indexed citations

14.

Hall, C. E., et al.. (1996). Structure-activity relationship of 17 structural analogues of N-butyric acid uponc-myc expression. International Journal of Cancer. 67(5). 724–729. 5 indexed citations

15.

Polack, Axel, Konstanze Hörtnagel, Alexander Pajic, et al.. (1996). c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.. Proceedings of the National Academy of Sciences. 93(19). 10411–10416. 109 indexed citations

16.

Bornkamm, Georg W., et al.. (1995). Among 17 inducers of differentiation only sodium butyrate causes a permanent down‐regulation of c‐myc in Burkitt's lymphoma. International Journal of Cancer. 62(6). 697–702. 11 indexed citations

17.

Hörtnagel, Konstanze, Axel Polack, Josef Mautner, Regina Feederle, & Georg W. Bornkamm. (1995). Regulatory Elements in the Immunoglobulin Kappa Locus Induce c-myc Activation in Burkitt’s Lymphoma Cells. Current topics in microbiology and immunology. 194. 415–422. 2 indexed citations

18.

Polack, Axel, Gerhard Laux, Manfred Hergenhahn, et al.. (1992). Short‐term assays for detection of conditional cancerogens I. Construction of DR‐CAT Raji cells and some of their characteristics as tester cells. International Journal of Cancer. 50(4). 611–616. 7 indexed citations

19.

Bornkamm, Georg W., et al.. (1991). Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle. Journal of General Virology. 72(10). 2391–2398. 11 indexed citations

20.

Laux, Gerhard, et al.. (1988). TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology. 162(2). 503–507. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact